Healthy Skepticism Library item: 4149
Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.
 
Publication type: news
Re: the promotion of phenazone/brompheniramine/quinine/caffeine/salicylamide
1990 Aug
Abstract:
E. Merck’s subsidiaries in Indonesia and Hong Kong are marketing Ilvico, a combination of phenazone/brompheniramine/quinine/caffeine/salicylamide, for upper respiratory tract infections. The scientific literature does not support the use of this product.
Keywords:
*analysis/Indonesia/Hong Kong/developing countries/Ilvico/E. Merck/quality of information/MaLAM/Medical Lobby for Appropriate Marketing/ETHICAL ISSUES IN PROMOTION: COMPANY STANDARDS/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPING COUNTRIES